HuGE Literature Finder
Records
1
-
4
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis : JTH 2017 Aug . Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer J H, Osterwalder J, Frauchiger B, Aschwanden M, Matter C M, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky |
Comparison of Aspirin and Naoxintong Capsule () with Adjusted-Dose Warfarin in Elderly Patients with High-Risk of Non-Valvular Atrial Fibrillation and Genetic Variants of Vitamin K Epoxide Reductase. Chinese journal of integrative medicine 2016 Feb . Wang Huan, Zhou Xiao-Kai, Zheng Li-Fan, Wu Xiao-Ying, Chen H |
Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study. American heart journal 2009 May 157 (5): 908-12. Suh Jung-Won, Baek Sang-Hong, Park Jin-Shik, Kang Hyun-Jae, Chae In-Ho, Choi Dong-Ju, Park Hun-Jun, Kim Pum-Joon, Seung Ki-Bae, Kim Hyo-S |
Prevalence of Warfarin Genotype Polymorphisms in Patients with Mechanical Circulatory Support. ASAIO journal (American Society for Artificial Internal Organs : 1992) 0 61 (4): 391-6. Awad Morcos, Czer Lawrence S C, Soliman Camelia, Mirocha James, Ruzza Andrea, Pinzas Joshua, Rihbany Kelsey, Chang David, Moriguchi Jaime, Ramzy Danny, Esmailian Fardad, Kobashigawa Jon, Arabia Francis |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: